ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CHFS CHF Solutions Inc

5.28
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CHF Solutions Inc NASDAQ:CHFS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.28 5.10 5.32 0 01:00:00

CHF Solutions, Inc. To Announce Fourth Quarter and Year-End 2018 Financial Results on February 20, 2019

13/02/2019 1:30pm

GlobeNewswire Inc.


CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more CHF Solutions Charts.

CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter and year-end 2018 financial results will be released on Wednesday, February 20, 2019. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.

To access the live webcast, please visit the Investors page of the CHF Solutions website at http://ir.chf-solutions.com or access the webcast directly at http://ir.chf-solutions.com/events.  Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 4589101.  An audio archive of the webcast will be available following the call on the Investor page at http://ir.chf-solutions.com/events.

About CHF Solutions

CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow® system for aquapheresis therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

CONTACTS:

INVESTORS:Claudia Napal DraytonChief Financial OfficerCHF Solutions, Inc.952-345-4205ir@chf-solutions.com

-Or-

Bret ShapiroManaging PartnerCORE IR516-222-2560brets@coreir.comwww.coreir.com

MEDIAJules AbrahamJQA Partners, Inc.917-885-7378jabraham@jqapartners.com

1 Year CHF Solutions Chart

1 Year CHF Solutions Chart

1 Month CHF Solutions Chart

1 Month CHF Solutions Chart

Your Recent History

Delayed Upgrade Clock